Cartesian Therapeutics (RNAC) Return on Assets (2016 - 2026)

Cartesian Therapeutics (RNAC) has 11 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

• Return on Assets for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Assets declined to 0.0% in Q1 2026 per RNAC's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Assets peaked at 0.0% in Q3 2022 and troughed at 0.01% in Q4 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
• The sharpest annual moves came in 2023 and 2024: Return on Assets decreased 1 bps in 2023, then rose 1 bps in 2024.
• A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then sank by 1043 bps to 0.01% in 2023, then jumped by 93 bps to 0.0% in 2024, then plunged by 399 bps to 0.0% in 2025, then fell by 19 bps to 0.0% in 2026.
• Business Quant data shows RNAC's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.